medigraphic.com
SPANISH

Alergia, Asma e Inmunología Pediátricas

Órgano Oficial del Colegio Mexicano de Alergia, Asma e Inmunología Pediátrica y de la Asociación Latinoamericana de Pediatría
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2005, Number 1

<< Back Next >>

Alerg Asma Inmunol Pediatr 2005; 14 (1)

Child’s asthma. Guides for its diagnosis and treatment

Stone AH, García CR, López GAL, Barragán MMM, Sánchez CG
Full text How to cite this article

Language: Spanish
References: 85
Page: 18-36
PDF size: 367.43 Kb.


Key words:

No keywords

Text Extraction

No abstract


REFERENCES

  1. Expert Panel Report II: Guidelines for the diagnosis and management of asthma. NHI publication No. 97-4053. 1997.

  2. Sorkness CA. Treatment of pediatric asthma. 1999; 126: 433.

  3. Björnsolottir US, Cypcar DM et al. Asthma: an inflammatory mediator soup. Allergy 1999; Suppl. 49(54): 55-61.

  4. Pérez MJ. Asma en el niño. Guía práctica. MPM Editores. 1997.

  5. Morrison SJ. The prevalence of asthma and wheezing in children. Br J Dis Chest 1976; 7: 70-73.

  6. Strachan PP. The epidemiology of childhood asthma. Allergy 1999; 54: 7-11.

  7. Asher MI, Keil U, Anderson HR et al. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Resp J 1995; 8(3): 483-91.

  8. Martínez FD, Wright AL et al. Asthma and wheezing in the first six years of life: The group Healt Medical Associates. N Engl J Med 1995; 332: 133-138.

  9. Peat JK, Li J. Reversing the trend: Reducing the prevalence of asthma. J Allergy Clin Immunol 1999; 103(1 part I): 1-10.

  10. Strannegärd O, Strannegärd IL. The causes of the increasing prevalence of allergy: is atopy a microbial deprivation disorder? Allergy 2000; 56(2): 91-102.

  11. Martínez FD. Recognizing early asthma. Allergy 1999; 49(54): 24-28.

  12. Halonen M et al. Two subphenotypes of childhood asthma that differ in maternal and paternal influences on asthma risk. Am J Resp Crit Care Med 1999; 160(2): 564-70

  13. Martínez FD. Present and future treatment of asthma in infants and young children. J Allergy Clin Immunol 1999; 104 (4 pt. 2): s169-74.

  14. Neuspiel DR et al. Sudden and unexpected natural death in childhood and adolescence. JAMA 1985; 254: 1321-1325.

  15. Martínez FD. Epidemiology of Childhood asthma in Pediatric Asthma. Marcel Drekkered. 1999: 1-39.

  16. Scheffer AL. Guidelines for diagnosis and management of asthma. J Allergy Clin Immunol 1991; 88: 427-38.

  17. Holgate ST. Mediator and Cytokine mechanisms in asthma: The altounyan Adress. Thorax 1993; 48: 103-110.

  18. Bentley AM, Qui Meng et al. Increases in activated T lymphocytes, eosinophiles and cytokine messenger RNA for IL5 and GM-CSF in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am J Respir Cell Mol Biol 1993; 8: 35-42.

  19. Robinson DS, Hammid Q et al. Activation of CD4 T cells increased TH2 type cytokine mRNA expression and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in atopic asthmatics. J Allergy Clin Immunol 1993; 92: 313-324.

  20. Dustin ML, Rothlein R et al. Induction by IL-1 and interferon-gamma: a tissue distribution, biochemetry and function of natural adherence molecule (ICAM-1). J Allergy Clin Immunol 1986; 137: 245-254.

  21. Thornhill MH, Wellcome SM et al. Tumor necrosis factor combines with IL-4 or IFN-gamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule - 1 dependent and independent binding mechanisms. J Immunol 1991; 146: 592-598.

  22. Laitinen LA, Heino M et al. Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis 1985; 131: 599-606.

  23. Kowalski MS, Diddier A et al. Neurogenic inflammation in the airways. Am Rev Respir Dis 1989; 140: 101-109.

  24. Sly MR. New guidelines for diagnosis and management of asthma. Ann Allergy Asma Immunol 1997; 78: 427-437.

  25. Hannaway PJ, Hopper GK. Cough variant asthma in children. JAMA 1982; 247: 206-8.

  26. Husbey S, Argettort L. Treatment of croup with nebulized steroid: a double blind placebo controlled study. Arch Dis Child 1993; 68: 352-5.

  27. Davies DP. Asthma: a follow-up statement from a international pediatric asthma consensus group. Arch Dis Child 1992; 67: 240-8.

  28. Niemeijer NR, De Monchy JG. Age dependency of sensitization to aeroallergens in asthmatics. Allergy 1992; 47: 431-5

  29. Strachan DP. Damp housing and childhood asthma: validation of reporting of symptoms. Br Med J 1988; 297: 1223-6.

  30. Vernoeff A, Burge H. Health risk assessment of fungi in home environments. Ann Allergy Asthma Immunol 1997; 78: 544-54.

  31. Castillejos M et al. Effects of ambient ozone on respiratory function and symptoms in school children in Mexico City. Am Rev Respir Dis 1992; 145: 276-282.

  32. Garofolo PJ, Kimpen J. Eosinophilic degranulation in the respiratory tract during naturally acquired respiratory syncitial virus infection. J Pediatr 1992; 120: 28-32.

  33. Foratiere F, Agabiti N. Passive smoking as a determinant of bronchial responsiveness in children. Am Resp Crit Care Med 1994: 149 : 365-70.

  34. Sarpong S, Wood R. Cockroach allergen in school dust. J Allergy Clin Immunol 1997; 99: 486-92.

  35. Siy M, O Donell R. Stabilization of asthma mortality. Ann Allergy Asthma Immunol 1997; 78: 347-54.

  36. Dodge RR, Burrows B. The prevalence and incidence of asthma and asthma like in general population sample. Am Rev Resp Dis 1980; 122: 567-75.

  37. Young S, Arnott J. Flow limitation during tidal expiration in symptoms free infants and the subsequent development of asthma . J Pediatr 1994; 124: 681-8.

  38. Prieto L, Gutierrez V, Morales C. Variability of peak espiratory flow rate in allergic rhinitis and mild asthma: relationship to maximal airway narrowing. Ann Allergy Asthma Immunol 1998; 80: 151-8.

  39. Gibson P, Mattoli S. Increase peak flow variability in children with asymptomatic hiperresponsiveness. Eur Respir J 1995: 1731-5.

  40. Gemou- Engesaeth V, Kay A. Activated pedphereal blood CD4 and CD8 T lymphocytes and child asthma: correlation with eosinophilia and disease severity. Pediatr Allergy Immunol.

  41. Zimmerman B, Stringer D. Prevalence of abnormalities found by sinus X-ray in childhood. J Allergy Clin Immunol 1987; 80(3 pt 1): 268-273.

  42. Zimmerman B, Gold M. Role of sinusitis in asthma. Pediatrician 1991; 18: 312-6.

  43. Hilman B. Genetic and Immunology aspects of Cystic Fibrosis. Ann Allergy Asthma Clin Immunol 1997; 79: 379-4.

  44. Practical guide for the diagnosis and management of asthma. National Asthma Education and Prevention Program. NIH publication No. 97-4053. Oct. 1997.

  45. Global strategy for asthma management and prevention WHO/NHLI workshop report. In: National Institutes of Healt, National Heart, Lung and Blood Institute. Publication number 95-3659, 1995; 70-107.

  46. Shapiro GG. Management of Pediatric Asthma: Care by the Specialist. Immunol Allerg Clin North Am 1998; 18(1): 1-24.

  47. Consenso Latinoamericano sobre Diagnóstico y Tratamiento del Asma. Rev Alergia 1994; Vol. XLI, Núm. 4, Suplemento.

  48. International Consensus Report on Diagnosis and Management of Asthma. International Asthma Management Project. Allergy 1992; 47: 1-61.

  49. Björksten B, Kjellman B, Zeiger RS. Development and Prevention of Allergic Disease in Chilhood. In: Middleton EJ, Reed CE, Ellis EF et al Eds. Allergy Principles and Practice. St Louis, Mosby, 1998: 816-837.

  50. Banov CH. Animal Proteins, Food, Environmental Control, Standardized Extracts. Ann Allergy 1987; 59: 31-32.

  51. Banov CH. Dust and Mites. Ann Allergy 1987; 59: 29-31.

  52. Björksten B. Environmental Issues in Chilhood Asthma. Eur Res Rev 1997; 7(40): 11-14.

  53. Brown HM et al. Effectiveness of an Acaricide in Management of House Dust Mite Allergy. Ann Allergy 1991; 67: 25-31.

  54. Williams-Gotti M, Sienra MJJ, Del Río NBE. Respuesta cutánea al alergeno de la cucaracha en pacientes alérgicos.

  55. Duff AL, Platts-Mills TAE. Alergenos y Asma. Clin Ped North Am 1992; 6: 1369-1384.

  56. Fernández-Caldas E, Fox RW. Environmental control of Indoor air pollution. Med Clin North Am 1992; 70: 935.

  57. Kumar P et al. Mold contamination of automobile air conditioner systems. Ann Allergy 1990; 64: 174-177.

  58. Menardo JL, Trigui F et al. The prevention of asthma. Pediatric Asthma An extract from Proceedings of the XVth European Congress of Allergology and Clinical Immunology. Paris, Francia, 10-15 may 1992.

  59. Wood RA. The importance of environmental control in the management of pediatric asthma. Immunol Allerg Clin North Am 1998; 18(1): 183-198.

  60. Cossio OE, Peña ENM, Abad BI, López PG, Huerta LJG. Infecciones virales de vías respiratorias bajas como factor sensibilizante para aeroalergenos. Seguimiento durante tres meses en pacientes pediátricos. Alergia, Asma e Inmunol Ped 1997; 6(2): 38-46.

  61. Vergara VJC, Peña ENM, Samayoa OAC, López PC, Huerta LJG. Asociación entre infecciones de vías respiratorias inferiores y asma alérgica en sujetos con y sin antecedentes heredofamiliares de atopía. Alergia, Asma e Inmunol Ped 1997: 6(2): 47-53.

  62. Kjellman NIM. Effects of parenteral smoking on IgE levels in children. Lancet 1981; 1: 933-4.

  63. Morgan WJ, Martínez TD. Factores de riesgo para la aparición de sibilancias y asma durante la niñez. Clin Ped North Am 1992; 6: 1279-98.

  64. Orysczyn MP et al. Relationships of total IgE level, skin prick test response and smoking habits. Ann Allergy 1991; 67: 355-8.

  65. Milner A. Asma infantil. Diagnóstico, tratamiento y manejo. Dunitz, Ltd, London. 1994.

  66. Plaut TF. Children with asthma. A manual for parents. 1988.

  67. Position Paper on Allergen Immunotherapy. Report of the BSACI Working Party. Clin Exp Allergy 1993; 23 (Suppl 3): 1-44.

  68. Glovsky MM et al. Effect of Maternal Immunotherapy on Immediate Skin Test Reactivity, Specific Rye-I-IgG and IgE Antibody and Total IgE of the Children. Ann Allergy 1991; 67: 21-25.

  69. Ortega MJA, Huerta HRE, Huerta LJG. Mecanismos inmunológicos de la Inmunoterapia específica y controversias sobre su uso. Alergia, Asma e Inmunol Ped 1997; 6(2): 54-57.

  70. Ownby DR. The Role of Immunotherapy in Childhood Asthma. Immunol and Allergy Clin North Am 1998: 199-210.

  71. Abramson M, Puy R, Weiner J. Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials. Am J Respir Crit Care Med 1995; 151: 969-974.

  72. Abramson M, Puy R, Weiner J. Immunotherapy in asthma an updated systematic review. Allergy 1999; 54: 1032-1041.

  73. Bousquet J, Lockey RF, Malling HJ. Allergen immunotherapy – therapeutic vaccines for allergic diseases. Allergy 1998; 53(Suppl 44): 4-42.

  74. Adkinson NF, Eggleston PA, Ency D et al. A controlled trial of immunotherapy for asthma in allergic children. N Engl J Med 1997; 336: 324- 331.

  75. Durham SR, Walker SM, Varga EM et al. Long term efficacy of grass pollen immunotherapy. N Engl J Med 1997; 336: 324-331.

  76. Deunoly P, Bousquet J, Michel FB. Immunotherapy in allergic rhinitis: A prevention for asthma? Curr Probl Dermatol 1999; 28: 119-123.

  77. Ball BD, Hill MR, Brenner M et al. Effect of low-dose trolendomycin on glucocorticoid pharmacokinetics and airway hyperresponsiveness in severely asthmatic children. Ann Allergy 1990; 65: 37-45.

  78. Szczeklilk A, Nizankowska E et al. Cycloporin for steroid-dependent asthma. Allergy 1991; 46: 312-315.

  79. Newman KB, Mason UG, Buchmeier A, Schmaling KB, Corsello P, Nelson HS. Failure of colchicine to reduce inhaled triamcinolone dose in patients with asthma. J Allergy Clin Immunol 1997; 99: 176-178.

  80. Charous BL. Open study of hydroxychloroquine in the treatment of severe symptomatic of corticosteroid-dependent asthma. Ann Allergy 1990; 65: 53-58.

  81. Shiner RJ, Nunn AJ, Chung KF, Geddes DM. Randomized, double-blind, placebo-controlled trial of methotrexate in steroid-dependent asthma. Lancet 1990; 336: 137-140.

  82. Mazer BD, Gelfan EW. An open label study of high-dose intravenous immunoglobulin in severe childhood asthma. J Allergy Clin Immunol 1991; 87: 976-983.

  83. Berlow BA, Liebhaber MI, Dyer Z, Spiegel TM. The effects of dapsone in steroid-dependent asthma. Ann Allergy Clin Immunol 1991; 87: 710-715.

  84. Kavuru MS, Wiedemann HP. Alternative Therapies. From Diagnosis and Management of Asthma. Cleveland Clinical Foundation. 1998.

  85. Martínez FD. Present and future of asthma in infants and young children. J Allergy Clin Immunol 1999; 104: 169-174.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Alerg Asma Inmunol Pediatr. 2005;14